Cervical Cancer Prevention Week
It’s Cervical Cancer Prevention Week from 23rd to 29th January 2023 - an annual awareness campaign to remind us why smear tests are so vital and to urge people to attend them. We’re supporting this campaign as the UK’s leading cervical cancer charity Jo’s Trust, states that only 1 in 3 individuals take up their invite to a smear test.
Welcome to the Nuffield Department of Women's & Reproductive Health. Established in 1937, we are one of the largest and most successful academic departments in the world in its field and we have been innovating, teaching, pioneering and evolving women's health for over 85 years. Our core purpose is to advance women's and reproductive health through research and teaching, and to improve the quality and delivery of women's healthcare across the globe.
Our worldwide acclaimed research covers four main themes; Reproductive Medicine & Genetics, Maternal & Fetal Health, Cancer and Global Health. We also run a range of clinical trials from women who are not currently pregnant, to those in the first trimester of pregnancy and onward, as well as general women's health studies.
Applications are still open for entry in 2023-24! We offer two postgraduate research programmes: a two year MSc by Research and a three year DPhil. These involve students undertaking independent research in their chosen area under the supervision of two or more experts in the field. In addition we offer a one year taught MSc in Clinical Embryology.
We have over 160 members in our department spread across eight sites in Oxford, consisting of post-graduate students, academic and research staff and professional staff. Our people are our life-blood and we are committed to ensuring they feel valued and nurtured as part of the Women's & Reproductive Health community.
Vaccine protects against pregnancy complications from COVID-19 Omicron variant
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has published, in the Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.
Venkatesh SS. et al, (2023)
Evaluation of maternal infections during pregnancy and childhood leukaemia in the offspring
HIRST J. et al, (2023), JAMA Network Open
Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: a systematic review and meta-analysis
Portwood C. et al, (2023), Frontiers in Medicine